Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/1997
10/23/1997WO1997039023A1 Cysteine-containing or methioine-containing peptides with immunomodulatory effects
10/23/1997WO1997039022A1 Novel compounds
10/23/1997WO1997039021A1 Targeted therapeutic or diagnostic agents and methods of making and using same
10/23/1997WO1997039019A1 Novel cationic cholesteryl derivatives containing cyclic polar groups
10/23/1997WO1997039018A1 New pregnane derivatives with no alpha-17 substitutent, their medicinal use, manufacturing method and its intermediaries and related compounds
10/23/1997WO1997039017A1 STREPTOCOCCUS PNEUMONIAE HISTIDYL tRNA SYNTHETASE
10/23/1997WO1997039016A1 NOVEL LysS PROTEINS FROM STREPTOCOCCUS PNEUMONIAE
10/23/1997WO1997039015A1 STREPTOCOCCUS PNEUMONIAE TYROSYL-tRNA SYNTHETASE
10/23/1997WO1997039014A1 STREPTOCOCCUS PNEUMONIAE ASPARTYL tRNA SYNTHETASE
10/23/1997WO1997039013A1 STREPTOCOCCUS PNEUMONIAE ALANYL tRNA SYNTHETASE
10/23/1997WO1997039012A1 STREPTOCOCCUS PNEUMONIAE METHIONYL tRNA SYNTHETASE
10/23/1997WO1997039011A1 STREPTOCOCCUS PNEUMONIAE ISOLEUCYL tRNA SYNTHETASE
10/23/1997WO1997039001A1 Isoxazolidine derivatives
10/23/1997WO1997039000A1 Thieno-pyridine sulfonamides, derivatives thereof and related compounds that modulate the activity of endothelin
10/23/1997WO1997038999A1 Acridone-derived compounds useful as antineoplastic and antiretroviral agents
10/23/1997WO1997038998A1 3-[(1,2,3,4-tetrahydroisoquinoline-2-yl)methyl]-8-azabicyclo[3.2.1]octane derivatives, their preparation and their application in therapeutics
10/23/1997WO1997038993A1 Isatin derivatives as acetylcholinesterase inhibitors and analgesics
10/23/1997WO1997038992A1 Piperidinylpyramidine derivatives
10/23/1997WO1997038991A1 Substituted tetracyclic tetrahydrofuran derivatives
10/23/1997WO1997038990A1 Novel n-aminoalkyl-1-biphenylenyl-2-carboxamides; new dopamine receptor subtype specific ligands
10/23/1997WO1997038989A1 N-aminoalkyl-2-anthraquinonecarboxamides; new dopamine receptor subtype specific ligands
10/23/1997WO1997038986A1 Substituted benzenesulfonamide derivatives as prodrugs of cox-2 inhibitors
10/23/1997WO1997038984A1 N-(amidinophenyl)-n'-(subst.)-3h-2,4-benzodiazepin-3-one derivatives as factor xa inhibitors
10/23/1997WO1997038983A1 Irreversible inhibitors of tyrosine kinases
10/23/1997WO1997038982A1 Novel carboxylic acid derivatives, their production and use
10/23/1997WO1997038981A1 NOVEL α-HYDROXYLIC ACID DERIVATIVES, THEIR PRODUCTION AND USE
10/23/1997WO1997038980A1 New carboxylic acid derivatives, their production and use
10/23/1997WO1997038977A1 Aminoisoquinolines and aminothienopyridine derivatives and their use as anti-inflammatory agents
10/23/1997WO1997038970A1 Phenylethanolaminotetralincarboxamide derivatives
10/23/1997WO1997038966A2 Cytoprotective compounds
10/23/1997WO1997038960A1 D-mannitol and its preparation
10/23/1997WO1997038731A1 Immunoliposomes that optimize internalization into target cells
10/23/1997WO1997038726A2 Hydrophobic carbomer complex compositions
10/23/1997WO1997038724A1 New indications for the use as medicaments of multipotent parapox immunity inducers from attenuated, non-immunogenic pox viruses or parapox viruses
10/23/1997WO1997038722A1 Novel compounds
10/23/1997WO1997038721A1 Novel compounds
10/23/1997WO1997038720A1 Novel compounds
10/23/1997WO1997038719A1 Novel compounds
10/23/1997WO1997038718A1 Novel compounds
10/23/1997WO1997038717A1 Novel compounds
10/23/1997WO1997038715A1 Novel compounds
10/23/1997WO1997038714A1 Novel compounds
10/23/1997WO1997038712A1 Intestinal trefoil proteins
10/23/1997WO1997038709A1 Use of growth hormone
10/23/1997WO1997038706A1 Glycopeptide compounds
10/23/1997WO1997038705A1 N-formyl hydroxylamine containing compounds useful as ace inhibitors and/or nep inhibitors
10/23/1997WO1997038703A1 Chimeric isoprenoid synthases and uses thereof
10/23/1997WO1997038699A2 Use of alkylaryl polyether alcohol polymers for the treatment of chronic pulmonary inflammation
10/23/1997WO1997038697A1 Sensitization of cells to radiation and chemotherapy
10/23/1997WO1997038696A1 Bisphosphonates as anti-inflammatory agents
10/23/1997WO1997038695A1 Dhea combination therapy
10/23/1997WO1997038694A1 Combination therapy for reducing the risks associated with cardiovascular disease
10/23/1997WO1997038693A1 Calcium channel blockers as human conjunctival mast cell degranulation inhibitors for treating ocular allergic conditions
10/23/1997WO1997038690A1 Agent for inhibiting leukocyte invasion of tissues
10/23/1997WO1997038689A2 Enteric-coated pharmaceutical compositions of mycophenolate
10/23/1997WO1997038688A1 Methods of treating immunopathologies using polyunsaturated fattyacids
10/23/1997WO1997038687A1 Buccal, non-polar spray for nitroglycerin
10/23/1997WO1997038686A1 Use of an osmolyte for treating the effects of an infection, an inflammation or an immune dysfunction
10/23/1997WO1997038685A1 Use of an osmolyte in the preparation of a medicament for treating complications resulting from ischemia
10/23/1997WO1997038684A1 Benzamide treatment of dementia associated with aids virus (hiv-1) infection
10/23/1997WO1997038683A1 Nitrone free radical trap treatment of dementia associated with aids virus (hiv-1) infection
10/23/1997WO1997038682A1 Biphenylamido derivatives as melatonergic agents
10/23/1997WO1997038681A1 A method for detection of potential co-antioxidants
10/23/1997WO1997038679A2 Fast disintegrating oral dosage form
10/23/1997WO1997038675A1 New pharmaceutical composition with anaesthetic effect
10/23/1997WO1997038674A1 Ophthalmic compound with extended dwell time on the eye
10/23/1997WO1997038665A2 Inhibitors of farnesyl-protein transferase
10/23/1997WO1997038664A2 A method of treating cancer
10/23/1997WO1997038663A2 Buccal, non-polar spray or capsule
10/23/1997WO1997038593A1 Diabetic supplement bar
10/23/1997WO1997038579A1 Emulsions of perfluoro compounds as solvents for nitric oxide (no)
10/23/1997WO1997035005A3 Cftr gene regulator
10/23/1997WO1997034586A3 Device and method for treating ophthalmic diseases
10/23/1997WO1997034568A3 Antipsoriatic compositions, method of making, and method of using
10/23/1997WO1997034565A3 Harpagoside-enriched extract from harpagophytum procumbens and processes for producing same
10/23/1997WO1997034137A3 Methods of the identification of pharmaceutically active compounds
10/23/1997WO1997031657A3 Use of labelled cck-b receptor ligands for the detection and localization of malignant human tumors
10/23/1997WO1997031019A3 Antipathogenic peptides and compositions comprising them
10/23/1997WO1997026918A3 Ligand directed enzyme prodrug therapy
10/23/1997WO1997026862A3 Improved concentrated injection and infusion solutions for intravenous administration
10/23/1997WO1997026853A3 Dna encoding galanin galr2 receptors and uses thereof
10/23/1997WO1997025068A3 Mesothelin antigen and methods and kits for targeting it
10/23/1997WO1997022368A3 Covalent lipid-phosphono-carboxylic acid conjugates and application thereof as antiviral medicaments
10/23/1997DE19616581A1 Mittel zur Hemmung der Leukozyteninvasion in Gewebe Means for inhibiting leukocyte invasion into tissues
10/23/1997DE19615812A1 Pharmazeutische Zubereitung enthaltend Diphosphonsäuren zur oralen Applikation Pharmaceutical preparation for oral administration containing diphosphonic acids
10/23/1997DE19615803A1 CELO-Virus CELO virus
10/23/1997DE19615710A1 Verfahren zur Gewinnung und Anwendung eines biologisch aktiven Eiweisstoffes - Kollagenfragment HF-COLL-18/514cf - in partiell aufgereinigter und synthetischer Form aus Körperflüssigkeiten zur Beeinflussung des Zellwachstums und der Diagnose von Kollagenerkrankungen sowie der Osteoporose Methods for obtaining and application of a biologically active Eiweisstoffes - collagen fragment HF-COLL-18 / 514cf - in partially purified form from body fluids and synthetic for influencing the cell growth and the diagnosis of collagen diseases and osteoporosis
10/23/1997DE19615576A1 New mono: and di:glucoside of glabridin
10/23/1997DE19615574A1 Use of mono and/or di:glucoside(s) of gentisin
10/23/1997DE19615461A1 Agent for taking out and removing heavy metals from human body
10/23/1997DE19615232A1 Neue Carbamoylderivate und deren Verwendung als 5-HT ¶1¶¶A¶-Antagonisten New carbamoyl derivatives and their use as 5-HT antagonists ¶1¶¶A¶
10/23/1997CA2254823A1 Emulsions of perfluoro compounds as solvents for nitric oxide (no)
10/23/1997CA2252403A1 Benzamide treatment of dementia associated with aids virus (hiv-1) infection
10/23/1997CA2252225A1 Use of a modified rev-responsive element (rre) in methods and compositions for combatting hiv infection
10/23/1997CA2252099A1 A cyclic hepta-peptide derivative from colonial ascidians, lissoclinum sp.
10/23/1997CA2252082A1 Hybrid interferon compositions and methods of use
10/23/1997CA2251972A1 Combination therapy for reducing the risks associated with cardiovascular disease
10/23/1997CA2251955A1 A method of treating cancer
10/23/1997CA2251945A1 Antisense inhibitors of vascular endothelial growth factor (vefg/vpf) expression
10/23/1997CA2251930A1 Biphenylamido derivatives as melatonergic agents
1 ... 6733 6734 6735 6736 6737 6738 6739 6740 6741 6742 6743 6744 6745 6746 6747 6748 6749 6750 6751 6752 6753 ... 7860